AR047705A1 - Composicion farmaceutica solida recubierta de uso veterinario para la administracion oral de principios activos de sabor desagradable y capa de recubrimiento - Google Patents

Composicion farmaceutica solida recubierta de uso veterinario para la administracion oral de principios activos de sabor desagradable y capa de recubrimiento

Info

Publication number
AR047705A1
AR047705A1 ARP050100557A ARP050100557A AR047705A1 AR 047705 A1 AR047705 A1 AR 047705A1 AR P050100557 A ARP050100557 A AR P050100557A AR P050100557 A ARP050100557 A AR P050100557A AR 047705 A1 AR047705 A1 AR 047705A1
Authority
AR
Argentina
Prior art keywords
coating layer
flavor
oral administration
pharmaceutical composition
solid pharmaceutical
Prior art date
Application number
ARP050100557A
Other languages
English (en)
Spanish (es)
Inventor
Mario Oda Kokuta
Original Assignee
Koenig S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koenig S A Lab filed Critical Koenig S A Lab
Publication of AR047705A1 publication Critical patent/AR047705A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP050100557A 2004-02-27 2005-02-17 Composicion farmaceutica solida recubierta de uso veterinario para la administracion oral de principios activos de sabor desagradable y capa de recubrimiento AR047705A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2004/000023 WO2005081612A2 (en) 2004-02-27 2004-02-27 Solid and coated pharmaceutical composition, for veterinary use and for oral administration of active principles of disagreeable taste, and coat

Publications (1)

Publication Number Publication Date
AR047705A1 true AR047705A1 (es) 2006-02-08

Family

ID=34891807

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100557A AR047705A1 (es) 2004-02-27 2005-02-17 Composicion farmaceutica solida recubierta de uso veterinario para la administracion oral de principios activos de sabor desagradable y capa de recubrimiento

Country Status (3)

Country Link
AR (1) AR047705A1 (pt)
BR (1) BRPI0418572A (pt)
WO (1) WO2005081612A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009023013A1 (en) * 2007-08-13 2009-02-19 Alpharma, Inc. Praziquantel and cmetidine compositions and methods
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
CN107468711B (zh) * 2017-08-21 2020-02-11 河南省奥林特药业有限公司 一种从猪肝中提取精制肝精膏的制备方法

Also Published As

Publication number Publication date
BRPI0418572A (pt) 2007-07-31
WO2005081612A2 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
Debruyne et al. Pharmacokinetics of antifungal agents in onychomycoses
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
KR20040063909A (ko) 구강, 비강 또는 질강에 항박테리아성, 항진균성, 및항바이러스성 연고를 전달하는 조성물과 방법
CA2521325A1 (en) Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
WO2006039499A3 (en) Method for improving the biovailability of orally delivered therapeutics
MX2007000008A (es) Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol.
EP2497466A3 (en) Preparation for oral administration
EP2395997A1 (en) Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
NO20045140L (no) Blandinger og fremgangsmate for transmukosal legemiddelavlevering og kryobeskyttelse
JP2007512371A5 (pt)
ES2610469T3 (es) Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio
JP2008512363A (ja) 経粘膜投与製剤の吸収を高める方法
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
WO2007000764A2 (en) Compositions and methods for enhancement of sexual function
MXPA05011724A (es) Productos dulces para liberar agentes farmaceuticamente activos a la garganta.
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
PE20001296A1 (es) El uso de una combinacion de tipranavir y ritonavir para mejorar la farmacocinetica del tipranavir
AR047705A1 (es) Composicion farmaceutica solida recubierta de uso veterinario para la administracion oral de principios activos de sabor desagradable y capa de recubrimiento
US20120014912A1 (en) Palatable pharmaceutical composition
BR0112847A (pt) Uso de uma forma de dosagem sólida
WO2006088945A3 (en) Granulysin peptides and methods of use thereof
ATE380545T1 (de) Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung
CN116322662A (zh) 用于治疗或预防与β冠状病毒感染相关的疾病的组合物和方法
JP2006517557A5 (pt)
WO2005058341A3 (en) Compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases

Legal Events

Date Code Title Description
FC Refusal